WELLS FARGO & COMPANY/MN - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$31,424
-48.2%
30,509
-41.6%
0.00%
Q2 2023$60,650
+30.2%
52,284
+69.5%
0.00%
Q1 2023$46,590
+86.8%
30,854
+209.3%
0.00%
Q4 2022$24,943
-57.0%
9,977
-27.4%
0.00%
Q3 2022$58,000
-54.7%
13,749
-70.0%
0.00%
Q2 2022$128,000
-77.9%
45,838
-54.7%
0.00%
Q1 2022$579,000
-39.1%
101,087
-2.9%
0.00%
Q4 2021$951,000
-47.4%
104,112
-38.4%
0.00%
Q3 2021$1,809,000
-30.0%
169,089
+1.5%
0.00%
-100.0%
Q2 2021$2,585,000
+43.9%
166,543
+50.2%
0.00%
Q1 2021$1,797,000
-59.5%
110,909
-47.1%
0.00%
-100.0%
Q4 2020$4,440,000
+35.4%
209,801
-5.2%
0.00%0.0%
Q3 2020$3,280,000
-16.5%
221,325
-17.1%
0.00%0.0%
Q2 2020$3,928,000
+372.7%
267,008
+277.3%
0.00%
Q1 2020$831,000
-31.8%
70,774
+36.5%
0.00%
Q4 2019$1,219,000
+2.4%
51,863
-19.4%
0.00%
Q3 2019$1,190,000
-23.5%
64,314
-23.1%
0.00%
Q2 2019$1,555,000
-83.3%
83,613
-78.0%
0.00%
-100.0%
Q1 2019$9,297,000
-20.0%
380,406
-15.1%
0.00%
-25.0%
Q4 2018$11,619,000
-19.2%
447,930
-1.5%
0.00%0.0%
Q3 2018$14,388,000
+39.3%
454,590
+71.0%
0.00%
+33.3%
Q2 2018$10,329,000
+518.5%
265,847
+339.1%
0.00%
Q1 2018$1,670,000
+184.5%
60,545
+86.6%
0.00%
Q4 2017$587,000
-72.1%
32,450
-75.1%
0.00%
-100.0%
Q3 2017$2,106,000
+252.8%
130,374
+202.1%
0.00%
Q2 2017$597,000
+0.3%
43,162
+9.1%
0.00%
Q1 2017$595,000
+105.2%
39,579
+78.8%
0.00%
Q4 2016$290,000
+51.0%
22,137
+98.2%
0.00%
Q3 2016$192,000
+14.3%
11,167
+20.0%
0.00%
Q2 2016$168,000
-22.6%
9,309
-18.4%
0.00%
Q1 2016$217,000
+3.3%
11,409
+45.3%
0.00%
Q4 2015$210,000
-60.2%
7,854
-63.7%
0.00%
Q3 2015$528,000
+132.6%
21,652
+196.7%
0.00%
Q2 2015$227,000
+530.6%
7,298
+180.3%
0.00%
Q1 2015$36,000
+200.0%
2,604
+120.7%
0.00%
Q4 2014$12,000
+20.0%
1,180
+0.7%
0.00%
Q3 2014$10,000
-44.4%
1,172
-21.0%
0.00%
Q2 2014$18,000
+1700.0%
1,483
+1383.0%
0.00%
Q1 2014$1,0001000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders